Bayer Group Consolidated Statements of Income

	1st Quarter 2007	1st Quarter 2008
€ million
Net sales	8,335	8,536
Cost of goods sold	(4,134)	(4,103)
Gross profit	4,201	4,433

Selling expenses	(1,807)	(1,902)
Research and development expenses	(625)	(633)
General administration expenses	(436)	(419)
Other operating income	143	287
Other operating expenses	(301)	(423)
Operating result (EBIT)	1,175	1,343

Equity-method loss	(14)	(10)
Non-operating income	242	135
Non-operating expenses	(446)	(400)
Non-operating result	(218)	(275)

Income before income taxes	957	1,068

Income taxes	(301)	(306)

Income from continuing operations after taxes	656	762

Income from discontinued operations after taxes	2,154	-

Income after taxes	2,810	762
of which attributable to minority interest	1	0
of which attributable to Bayer AG stockholders (net income)	2,809	762

Earnings per share (€)
From continuing operations
Basic^*	0.82	0.96
Diluted^*	0.82	0.96

From discontinued operations
Basic^*	2.62	-
Diluted^*	2.62	-

From continuing and discontinued operations
Basic^*	3.44	0.96
Diluted^*	3.44	0.96